The Swiss biotech industry achieved record revenues and attracted impressive private financing rounds as immunology products came to the fore, new research shows.
Breaking Barriers: The Benefits Of Being A Swiss Biotech
The lack of distractions from a large domestic market and a close proximity of research centers are just two advantages for the flourishing Swiss biotech sector, which enjoyed a bumper year in 2021, says its industry association.
